ESC 365 - P300-mediated inactivation of p53 protects against doxorubicin-induced cardiotoxicity

ESC Premium Access

P300-mediated inactivation of p53 protects against doxorubicin-induced cardiotoxicity

Session: Poster Session 6 - Basic science heart failure

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Mr M. Adam (Toronto, CA)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Mr Mohamed Adam

St. Michael's Hospital, Toronto (Canada)

0 follower

9 more presentations in this session

Epigenetic modifications and gene expressions in Mybpc3 knockout mice

Speaker: Doctor M. Hossain (Stockholm, SE)

Angiotensin receptor-neprilysin inhibitor preserved cardiac function via improving angiogenetic ability in mice model of atherosclerosis

Speaker: Doctor Y. Suematsu (Fukuoka, JP)

The BNP reporter mouse by knock-in technology is useful for the analysis of mechanism in reactivation of BNP in adult heart

Speaker: Professor R. Okamoto (Tsu, JP)

Cardiac abnormalities after induction of endoplasmic reticulum stress are associated with mitochondrial dysfunction and connexin43 expression

Speaker: Professor G. Tse (Hong Kong, CN)

Protective effect of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in spontaneous hypertensive rats

Speaker: Doctor T. Lin (Taipei, TW)

Access the full session

Poster Session 6 - Basic science heart failure

Speakers: Mr M. Adam, Doctor M. Hossain, Doctor Y. Suematsu, Professor R. Okamoto, Professor G. Tse...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources